Investigations: 24-hour uptake of 1311, 4 % dose and 48-hour PB131I 0-2% dose/l; PBI 2 0 pg/100 ml; cholesterol 375 mg/100 ml; LATS and thyroid antibodies not detected. The serum TSH level (measured by a radioimmunoassay using a double antibody technique) was above 2,000 micro units/ml (normal < 5 micro units/ml).
Skull X-ray showed an enlarged pituitary fossa (22 x 18 mm). The cortisol and HGH responses to insulin-induced hypoglyczemia (minimum blood sugar level 25 mg/100 ml) were impaired. Urinary gonadotrophins (regular menses) were normal at 20 mg IRP-HMG/24 h. Response to treatment: Thyroxine therapy was given and within two weeks the uveal effusion had resolved (cf. pleural, pericardial and peritoneal effusions in myxcedema responding to thyroid replacement). TSH level fell rapidly to 15 micro units/ml within four weeks of treatment and on 0-2 mg thyroxine was almost within normal limits (Fig 1) . The cortisol response to hypoglycwmia (minimum blood sugar 30 mg/100 ml) was also normal (15-26 ,ug/100 ml), but the HGH rise was slightly impaired (3-4-9 5 ng/ml (Bielschowsky 1955) . Likewise in man, frank neoplastic change may occur in parathyroids made hyperplastic by longstanding renal disease or malabsorption (Davies et al. 1968 ). Thus, there are analogies for the concept that hypothyroidism in this patient, dating from thyroidectomy twenty-five years earlier, led to pituitary hyperplasia and that treatment may have prevented the development of neoplasia.
